Stocks / NYSE / Catalent, Inc.

Catalent, Inc.

Our Opinion

Catalent, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their drugs, research and therapies.

Supporting Evidence:

They provide “Solubility screening for animal testing” as per the company’s Corporate Brochure.

Company Description

Catalent, Inc. is a holding company, which engages in the research, development and marketing of pharmaceutical products. It operates through the following segments: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services. The Softgel Technologies segment engages in formulation, development and manufacturing of prescription and consumer health soft capsules, or softgels including traditional softgel capsules; and vegicaps and optishell capsules. The Drug Delivery Solutions segment includes formulation, development and manufacturing of prescription and consumer and animal health products using its proprietary optimelt, optipact, optiform and zydis technologies. The Clinical Supply Services segment includes in manufacturing, packaging, labeling, storage, distribution and inventory management for global clinical trials of drugs and biologics for customer required patient kits; fastChain demand-led clinical supply service; clinical e-solutions and informatics; and global comparator sourcing services. The company was founded in April 2007 and is headquartered in Somerset, NJ. [Source: MarketWatch]

Company Website: